Neuroimaging for precision medicine in psychiatry-Reference-Cited by-同舟云学术

Neuroimaging for precision medicine in psychiatry

Published:2024-07-22 Issue: Volume: Page:
ISSN:0893-133X
Container-title:Neuropsychopharmacology
language:en
Short-container-title:Neuropsychopharmacol.

Author:

Williams Leanne M.^ORCID,Whitfield Gabrieli Susan

Funder

U.S. Department of Health & Human Services | NIH | National Institute of Mental Health

Publisher

Springer Science and Business Media LLC

Link

https://www.nature.com/articles/s41386-024-01917-z.pdf

Reference137 articles.

1. Friedrich MJ. Depression is the leading cause of disability around the world. JAMA. 2017;317:1517 https://doi.org/10.1001/jama.2017.3826

2. AAP-AACAP-CHA. Declaration of a National Emergency in Child and Adolescent Mental Health. American Academy of Pediatrics. https://www.aap.org/en/advocacy/child-and-adolescent-healthy-mental-development/aap-aacap-cha-declaration-of-a-national-emergency-in-child-and-adolescent-mental-health/2021 October 19, 2021.

3. Collaborators C-MD. Global prevalence and burden of depressive and anxiety disorders in 204 countries and territories in 2020 due to the COVID-19 pandemic. Lancet. 2021;398:1700–12. https://doi.org/10.1016/S0140-6736(21)02143-7

4. Collaborators GBDMD. Global, regional, and national burden of 12 mental disorders in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Psychiatry. 2022;9:137–50. https://doi.org/10.1016/S2215-0366(21)00395-3

5. Curtin SC, Xu J. Death rates for leading causes of death for people aged 25–44 among the three largest race and ethnicity groups: United States, 2000–2020. NCHS Data Brief No. 451. 2022. Hyattsville, MD: National Center for Health Statistics; 2022.